Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Remifentanil: a new opioid

P S Glass1

  • 1Department of Anesthesiology, Duke University, Durham, NC 27710, USA.

Journal of Clinical Anesthesia
|November 1, 1995
PubMed
Summary

Remifentanil offers rapid onset and offset of effect, making it a highly titratable opioid. This unique pharmacokinetic profile ensures suitability for both short-term and long-term analgesia with predictable recovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A case of tracheal injury after emergent endotracheal intubation: a review of the literature and causalities.

Anesthesia and analgesia·2001
Same author

Does functional ability in the postoperative period differ between remifentanil- and fentanyl-based anesthesia?

Journal of clinical anesthesia·2001
Same author

Automated anesthesia: fact or fantasy?

Anesthesiology·2001
Same author

Duration of action of vecuronium after an intubating dose of rapacuronium, vecuronium, or succinylcholine.

Anesthesia and analgesia·2001
Same author

Assessment of depth of anesthesia and postoperative respiratory recovery after remifentanil- versus alfentanil-based total intravenous anesthesia in patients undergoing ear-nose-throat surgery.

Anesthesiology·2001
Same author

Arm pain as an unusual presentation of postdural puncture intracranial hypotension.

Anesthesia and analgesia·2000

Area of Science:

  • Pharmacology
  • Anesthesiology

Background:

  • Remifentanil is a potent mu opioid agonist.
  • Understanding its pharmacokinetic and pharmacodynamic properties is crucial for clinical application.

Purpose of the Study:

  • To describe the unique pharmacokinetic and pharmacodynamic properties of remifentanil.
  • To evaluate its suitability for various clinical durations of administration.

Main Methods:

  • Pharmacodynamic and pharmacokinetic analysis of remifentanil.
  • Review of clinical data regarding its administration and recovery.

Main Results:

  • Remifentanil exhibits pharmacodynamic properties similar to other mu opioid agonists.
  • Unique rapid onset and offset of action, independent of administration duration.
  • Demonstrates high titratability for precise dose adjustment.

Conclusions:

  • Remifentanil's pharmacokinetic profile allows for predictable and rapid recovery.
  • Suitable for short-term and long-term analgesia.
  • Offers a valuable option for anesthesia and intensive care settings.

Related Experiment Videos